Compare MDCX & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MDCX | INMB |
|---|---|---|
| Founded | 2008 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.4M | 49.2M |
| IPO Year | N/A | 2019 |
| Metric | MDCX | INMB |
|---|---|---|
| Price | $1.47 | $1.65 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 3 |
| Target Price | ★ $23.50 | $4.30 |
| AVG Volume (30 Days) | 371.0K | ★ 496.6K |
| Earning Date | 11-14-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $50,000.00 |
| Revenue This Year | N/A | $264.29 |
| Revenue Next Year | N/A | $14,337.26 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 19.05 |
| 52 Week Low | $1.49 | $1.38 |
| 52 Week High | $8.94 | $11.64 |
| Indicator | MDCX | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 32.56 | 41.71 |
| Support Level | $1.49 | $1.75 |
| Resistance Level | $2.03 | $1.90 |
| Average True Range (ATR) | 0.16 | 0.14 |
| MACD | -0.03 | -0.04 |
| Stochastic Oscillator | 2.50 | 2.24 |
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.